Free Trial

Jasper Therapeutics (JSPRW) Competitors

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free JSPRW Stock Alerts
$0.15
0.00 (0.00%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media

JSPRW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Jasper Therapeutics stock or one of its competitors? The main competitors of Jasper Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Jasper Therapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and Jasper Therapeutics (NASDAQ:JSPRW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Jasper TherapeuticsN/AN/AN/AN/AN/A

180 Life Sciences and Jasper Therapeutics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Jasper TherapeuticsN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Jasper Therapeutics N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Jasper Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Jasper Therapeutics. Jasper Therapeutics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
Jasper Therapeutics Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Jasper Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

180 Life Sciences beats Jasper Therapeutics on 2 of the 2 factors compared between the two stocks.

Get Jasper Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JSPRW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JSPRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JSPRW vs. The Competition

Export to Excel
MetricJasper TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$228.16M$4.88B$7.56B
Dividend YieldN/A3.61%2.99%3.94%
P/E RatioN/A71.51206.5819.16
Price / SalesN/A12,714.522,361.6682.58
Price / CashN/A11.0647.0535.03
Price / BookN/A8.554.774.38
Net IncomeN/A-$36.16M$103.53M$214.13M
7 Day Performance-11.94%0.72%0.79%1.87%
1 Month Performance-20.83%-4.90%-7.51%-5.24%
1 Year Performance-13.18%49.21%9.20%8.38%

Jasper Therapeutics Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars		$0.01
flat		N/A-45.9%$0.00N/A0.004Short Interest ↓
Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars		$0.11
flat		N/AN/A$0.00$253,573.000.002Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars		$0.21
flat		N/A-18.2%$0.00N/A0.00121Short Interest ↓
APLMW
Apollomics
0 of 5 stars		$0.03
+66.7%		N/A-73.7%$0.00N/A0.0059Short Interest ↓
News Coverage
Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars		$0.02
flat		N/A-78.5%$0.00N/A0.005Positive News
BCDAW
BioCardia
0 of 5 stars		$0.02
-34.5%		N/A-97.1%$0.00$477,000.000.0030Positive News
Gap Down
BCTXW
BriaCell Therapeutics
0 of 5 stars		$1.01
-9.8%		N/A-68.6%$0.00N/A0.0016Positive News
Gap Down
CDIOW
Cardio Diagnostics
0 of 5 stars		$0.07
-21.2%		N/A-76.2%$0.00$17,065.000.007Positive News
Gap Down
High Trading Volume
CTCXW
Carmell
0 of 5 stars		$0.07
-35.5%		N/AN/A$0.00$3.73M0.009Positive News
SAVAW
Cassava Sciences
0 of 5 stars		$0.87
+11.5%		N/AN/A$0.00N/A0.0029Positive News
Gap Down
High Trading Volume

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:JSPRW) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The World's First "$20 Trillion Drug?"
Behind the Markets
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press